How eating differs across GLP-1 medications

Two molecules, several brand names

Almost everything prescribed in this category comes down to two molecules. Semaglutide is sold as Ozempic for type 2 diabetes, as Wegovy for weight management, and as Rybelsus in tablet form. Tirzepatide is sold as Mounjaro in Australia and the UK, and as Zepbound in the US. Saxenda is liraglutide, an older and shorter-acting option taken daily rather than weekly.

That matters because two names on a pharmacy label can be the same drug. If you have moved from Ozempic to Wegovy, you have not changed molecule; you have changed the licensed use and the top of the dose range.

What the molecules do differently at the plate

Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on the GIP receptor as well. Both slow how quickly the stomach empties and both dampen appetite signalling, which is why the practical advice is so similar across them: protein first, smaller portions, more eating occasions, deliberate fluid.

The difference people describe is degree rather than direction. On tirzepatide, particularly at the higher doses, the appetite drop is commonly reported as sharper, and volume becomes the limiting factor sooner. That pushes nutrient density from a good idea to the whole strategy, because there is less room to waste on foods that are mostly bulk.

Oral semaglutide is the exception to the "it is all the same" rule, because the tablet has its own instructions about an empty stomach, a small sip of water, and waiting before you eat or take anything else. Those instructions come with the medication rather than from a food article. Follow them and ask your pharmacist if anything is unclear.

What is the same on all of them

• Protein leads. It is the first thing to fall when appetite drops and the thing doing most to support lean muscle while you lose weight.
• Volume down, frequency up. Four to six small eating occasions beat three full plates on every one of these medications.
• Fat and large portions sit heaviest. Slower gastric emptying makes rich and oversized meals the most commonly regretted ones.
• Fluid has to be deliberate. Thirst follows appetite downwards, and under-hydration shows up as headaches, fatigue and constipation.
• Fibre goes up gradually, alongside fluid. A fibre jump on its own usually produces bloating rather than progress.
• Rough days need a plan made in advance. Nobody makes good food decisions while queasy.

The dose ladder matters more than the brand

If one thing on this page is worth taking away, it is this: eating is hardest in the one to two weeks after a dose increase, on every one of these medications. That is when appetite drops again and tolerance resets. The medications differ mainly in how many of those weeks you go through.

• Ozempic usually steps 0.25 mg, 0.5 mg, 1 mg, with 2 mg available. A short ladder.
• Wegovy usually steps 0.25, 0.5, 1, 1.7 then 2.4 mg, roughly four weeks apart, so around four months of intermittent adjustment.
• Mounjaro usually starts at 2.5 mg, then 5 mg, then 2.5 mg increments up to 15 mg, with the higher steps the ones people describe as most noticeable.

These are the usual prescribing schedules, not a recommendation. Your prescriber decides your schedule, holds a step longer when it makes sense, and may keep you at a lower dose indefinitely.

If you are switching

Moving between Ozempic and Wegovy changes the dose, not the molecule, so the food habits carry over intact. Moving between semaglutide and tirzepatide changes both, and the common report is the same effect arriving harder. Either way, treat the switch as a return to week one: restock the gentle options, drop the portion sizes again, and keep the protein routine you already know works.

Common questions

Which GLP-1 medication is easiest to eat on?

There is no general answer, because tolerance is individual and the same person can find one dose comfortable and the next difficult. What people describe consistently is that the direction is the same on all of them, and that the hardest stretch on any of them is the two weeks after a dose increase.

Are Ozempic and Wegovy the same drug?

Both are semaglutide. Ozempic is licensed for type 2 diabetes with a top dose of 2 mg; Wegovy is licensed for weight management with a top dose of 2.4 mg and a longer ladder to reach it. For food purposes the principles are identical.

Are Mounjaro and Zepbound the same drug?

Yes. Both are tirzepatide. Mounjaro is the brand name used in Australia and the UK; Zepbound is the US brand licensed for weight management. Nothing about eating differs between them.

Does eating change when I switch medications?

The principles carry over: protein first, smaller and more frequent, fluid deliberately, gentle options stocked in advance. What resets is the dose ladder, so expect another round of adjustment weeks, and expect to revisit portion sizes if you are moving from semaglutide to tirzepatide.